The British Society for Immunology (BSI) Immune Therapies Summit is a unique event bringing together sector leaders from industry, academia and clinical spheres to discuss novel approaches and future challenges in immune therapies research. With internationally renowned speakers and an engaging and interactive programme, this inaugural event is an exceptional opportunity to build your cross-sector networks, learn more about current insights and trends in immune therapy development and be part of the conversation to drive forward the next iteration of immunotherapy research for patient benefit.

TOPIC COVERED

Novel approaches and future challenges in immune therapies research.

WHO SHOULD ATTEND?  

The BSI Immune Therapies Summit is aimed at senior leaders from industrial, academic and clinical research settings who are passionate about accelerating immune therapy development and building their cross-sector networks in this field.

SPEAKERS

Keynote: Paul Peter Tak, President & CEO, Candel Therapeutics

Plenary speakers: 

• Pippa Corrie, University of Cambridge
• Dan Cua, Janssen Pharmaceutical
• Kyle Holen, Moderna
• Marie Kosco-Vilbois, AC Immune
• Kara Lassen, Roche Pharma Research and Early Development
• Virginia Pascual, Drukier Institute for Children’s Health
• Georg Schett, University of Erlangen
• Michal Schwartz, Weizmann Institute of Science

For more information, please contact: [email protected]